1 | international gene synthesis consortium | | | | | | | 6 | 0.31% |
2 | international gene synthesis consortium? | | | | | | | 6 | 0.31% |
3 | a member of the | | | | | | | 3 | 0.15% |
4 | synthesis consortium about members | | | | | | | 2 | 0.10% |
5 | gene synthesis consortium about | | | | | | | 2 | 0.10% |
6 | apply a common protocol | | | | | | | 2 | 0.10% |
7 | screening protocols for synthetic | | | | | | | 2 | 0.10% |
8 | protocols for synthetic dna | | | | | | | 2 | 0.10% |
9 | for synthetic dna products | | | | | | | 2 | 0.10% |
10 | synthetic dna products and | | | | | | | 2 | 0.10% |
11 | dna products and services | | | | | | | 2 | 0.10% |
12 | mission is to enable | | | | | | | 2 | 0.10% |
13 | including gene synthesis and | | | | | | | 2 | 0.10% |
14 | services including gene synthesis | | | | | | | 2 | 0.10% |
15 | at the university of | | | | | | | 1 | 0.05% |
16 | member of the global | | | | | | | 1 | 0.05% |
17 | the university of illinois | | | | | | | 1 | 0.05% |
18 | urbanachampaign and a member | | | | | | | 1 | 0.05% |
19 | and a member of | | | | | | | 1 | 0.05% |
20 | biofoundry based at the | | | | | | | 1 | 0.05% |
21 | based at the university | | | | | | | 1 | 0.05% |
22 | advanced biomanufacturing ibiofab is | | | | | | | 1 | 0.05% |
23 | automated biofoundry based at | | | | | | | 1 | 0.05% |
24 | an automated biofoundry based | | | | | | | 1 | 0.05% |
25 | the global biofoundry alliance | | | | | | | 1 | 0.05% |
26 | for advanced biomanufacturing ibiofab | | | | | | | 1 | 0.05% |
27 | foundry for advanced biomanufacturing | | | | | | | 1 | 0.05% |
28 | biological foundry for advanced | | | | | | | 1 | 0.05% |
29 | illinois biological foundry for | | | | | | | 1 | 0.05% |
30 | startup ecosystem ibiofab the | | | | | | | 1 | 0.05% |
31 | and startup ecosystem ibiofab | | | | | | | 1 | 0.05% |
32 | of the global biofoundry | | | | | | | 1 | 0.05% |
33 | synthetic biology and biological | | | | | | | 1 | 0.05% |
34 | global biofoundry alliance we | | | | | | | 1 | 0.05% |
35 | cellular scale and provide | | | | | | | 1 | 0.05% |
36 | such highthroughput screening and | | | | | | | 1 | 0.05% |
37 | collaborators such highthroughput screening | | | | | | | 1 | 0.05% |
38 | and collaborators such highthroughput | | | | | | | 1 | 0.05% |
39 | customers and collaborators such | | | | | | | 1 | 0.05% |
40 | provide services for our | | | | | | | 1 | 0.05% |